Atlas Trials

Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer

Clinical trial NCT00014287 · WITHDRAWN

Trial details

NCT number
NCT00014287
Sponsor
University of Pittsburgh
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2000-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.